U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H11NO5
Molecular Weight 213.1873
Optical Activity ( - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DROXIDOPA

SMILES

N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O

InChI

InChIKey=QXWYKJLNLSIPIN-JGVFFNPUSA-N
InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1

HIDE SMILES / InChI
Molecular Formula C9H11NO5
Molecular Weight 213.1873
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
123738
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:01:18 UTC 2023
Edited
by admin
on Sat Dec 16 17:01:18 UTC 2023
Record UNII
J7A92W69L7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DROXIDOPA
DASH   INN   JAN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
droxidopa [INN]
Common Name English
DOPS
Code English
DROXIDOPA [VANDF]
Common Name English
(-)-(2S,3R)-2-AMINO-3-(3,4-DIHYDROXYPHENYL)-3-HYDROXYPROPANOIC ACID
Systematic Name English
DROXIDOPA [MI]
Common Name English
DROXIDOPA [ORANGE BOOK]
Common Name English
L-THREO-DOPS
Common Name English
THREO-3,4-DIHYDROXYPHENYLSERINE, L-
Common Name English
Droxidopa [WHO-DD]
Common Name English
DROXIDOPA [USAN]
Common Name English
L-TYROSINE, .BETA.,3-DIHYDROXY-, (.BETA.R)-
Common Name English
NORTHERA
Brand Name English
L-DOPS
Code English
DROXIDOPA [JAN]
Common Name English
DROXIDOPA [MART.]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 229506
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
EU-Orphan Drug EU/3/07/465
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
WHO-ATC C01CA27
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
EU-Orphan Drug EU/3/07/466
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
NCI_THESAURUS C38149
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
Code System Code Type Description
USAN
UU-114
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
DRUG CENTRAL
971
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
DAILYMED
J7A92W69L7
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
WIKIPEDIA
L-DOPS
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
MESH
D015103
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
CHEBI
60568
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
NCI_THESAURUS
C73266
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
RXCUI
1489913
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY RxNorm
SMS_ID
100000081029
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
EPA CompTox
DTXSID6046422
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
NDF-RT
N0000178478
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY Increased Blood Pressure [PE]
CAS
23651-95-8
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
IUPHAR
7391
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
FDA UNII
J7A92W69L7
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
ChEMBL
CHEMBL2103827
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
PUBCHEM
92974
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
DRUG BANK
DB06262
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
EVMPD
SUB06420MIG
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
MERCK INDEX
m4774
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY Merck Index
INN
6120
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
CHEBI
31524
Created by admin on Sat Dec 16 17:01:21 UTC 2023 , Edited by admin on Sat Dec 16 17:01:21 UTC 2023
PRIMARY
Related Record Type Details
ALPHA-1A ADRENERGIC RECEPTOR
TARGET -> AGONIST
BETA-3 ADRENERGIC RECEPTOR
TARGET -> AGONIST
ALPHA-2A ADRENERGIC RECEPTOR
TARGET -> AGONIST
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
BETA-1 ADRENERGIC RECEPTOR
TARGET -> AGONIST
CATECHOL O-METHYLTRANSFERASE
METABOLIC ENZYME -> SUBSTRATE
Structure of THREO-DIHYDROXYPHENYLSERINE
RACEMATE -> ENANTIOMER
AROMATIC-L-AMINO-ACID DECARBOXYLASE
METABOLIC ENZYME -> SUBSTRATE
ALPHA-2B ADRENERGIC RECEPTOR
TARGET -> INHIBITOR
ALPHA-2C ADRENERGIC RECEPTOR
TARGET -> INHIBITOR
ALPHA-1D ADRENERGIC RECEPTOR
TARGET -> AGONIST
ALPHA-1B ADRENERGIC RECEPTOR
TARGET -> AGONIST
BETA-2 ADRENERGIC RECEPTOR
TARGET -> AGONIST
Related Record Type Details
Structure of 4-METHYLCATECHOL
METABOLITE -> PARENT
Structure of 3,4-DIHYDROXYBENZOIC ACID
METABOLITE -> PARENT
Structure of 3-METHOXY-4-HYDROXYPHENYLGLYCOL, (-)-
METABOLITE -> PARENT
Structure of 3,4-DIHYDROXYPHENYLGLYCOL, (R)-
METABOLITE -> PARENT
Structure of (.BETA.R)-.BETA.-HYDROXY-3-METHOXY-L-TYROSINE
METABOLITE -> PARENT
MAJOR
Structure of VANILLIC ACID
METABOLITE -> PARENT
Structure of NOREPINEPHRINE
METABOLITE ACTIVE -> PRODRUG
Related Record Type Details
Structure of (R)-N-(2-BENZOYLPHENYL)-1-BENZYLPYRROLIDINE-2-CARBOXAMIDE
IMPURITY -> PARENT
Structure of 2H-ISOINDOLE-2-ACETIC ACID, .ALPHA.-((R)-(3,4-DIHYDROXYPHENYL)HYDROXYMETHYL)-1,3-DIHYDRO-1,3-DIOXO-, (.ALPHA.S)-
IMPURITY -> PARENT
Related Record Type Details
Structure of NOREPINEPHRINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Tmax PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966